Vericel Corp (NAS:VCEL)
$ 51.53 0.4 (0.78%) Market Cap: 2.50 Bil Enterprise Value: 2.49 Bil PE Ratio: 9,999.00 PB Ratio: 10.68 GF Score: 79/100

Vericel Corp at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 11:30AM GMT
Release Date Price: $36.52 (+7.22%)
Unidentified Analyst

Thanks for joining us for day 2 of the MS Healthcare Conference. I'll point to teleconference website for the requisite legal disclaimer. I'm pleased to welcome Nick Colangelo from Vericel. Nick, maybe we can start off with a little bit of general information, particularly for investors who are less familiar with Vericel.

Questions & Answers

Unidentified Analyst

Can you provide a little bit of background on the profile of the company and going forward?

Dominick C. Colangelo
Vericel Corporation - CEO, President & Director

Yes. Certainly and I want to, first of all, say thanks for having us here. We're really excited to be part of the conference. And as always, we say that this discussion will contain forward-looking statements until investors should refer to our documents on file with the SEC for further information.

So Vericel is a leader in advanced therapies for the sports medicine and the severe burn care market. We have a portfolio of highly innovative advanced therapies that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot